PharmaEssentia Corporation (TPE:6446)

Taiwan · Delayed Price · Currency is TWD

689.00

+19.00 (2.84%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development of New Drugs			5.11B	2.88B	656.51M	557.26M	305.69M
Research and Development of New Drugs Growth			77.15%	339.00%	17.81%	82.29%	1065.16%
Total			5.11B	2.88B	656.51M	557.26M	305.69M
Total Growth			77.15%	339.00%	17.81%	82.29%	1065.16%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			322.08M	306.60M	342.98M	282.15M	12.23M
Taiwan Growth			5.05%	-10.61%	21.56%	2207.43%	230.93%
Asia (Excluding Taiwan)			131.31M	30.29M	35.92M	6.23M	-
Asia (Excluding Taiwan) Growth			333.46%	-15.65%	476.58%	-	-
Europe			147.71M	613.83M	205.24M	268.88M	293.46M
Europe Growth			-75.94%	199.08%	-23.67%	-8.38%	1201.91%
America			4.50B	1.93B	72.37M	-	-
America Growth			133.23%	2568.61%	-	-	-
Total			5.11B	2.88B	656.51M	557.26M	305.69M
Total Growth			77.15%	339.00%	17.81%	82.29%	1065.16%

Source: S&P Global Market Intelligence.